With the onset of the COVID-19 pandemic, clinical trial sponsor companies and CROs hastened to implement virtual trial technologies. The virtual visits and digital data exchange would enable them to start or continue studies, despite government mandates requiring patients and staff to stay at home.
During the COVID-19 lockdown, in April and May 2020, ERT surveyed clinical professionals on how the demands of the pandemic were affecting their organizations’ use and planned use of virtual trial technologies. Download the free eBook, Virtual Trials and the COVID-19 Pandemic: The State of Clinical Trials, to learn about their responses and industry trends.
Key takeaways from the report include:
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.